| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_969984b7820440f67866632ad67c8dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b6aa9b90bd14778bb591454cce0a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f83aa1aa79a45aa2349bb2f5dc1ef27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1768f4161fcea14837020ce926c01a98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d312393e2689a07f5e7d2e138ad86b7f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 |
| filingDate |
2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85baf1ba98c6eb6ce82a3cccf32abb57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0128b054ca86df93ae77d6ae500ff858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6ee02d55d8d496ec9997876805119bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcbd71e1da5b5c9c5a955c2b6a37f90d |
| publicationDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9662368-B2 |
| titleOfInvention |
Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| abstract |
The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNFα in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation. |
| priorityDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |